The positive reaction of Wall in Monday’s meeting, after the slump brought to the American market by the location of the new mutated strain Omicron, does not seem to continue, as the futures on the New York Stock Exchange fall after Moderna CEO Stefan Bancel predicts that existing vaccines will be much less effective in dealing with the new mutation.
In particular, St. Banchel warned that it would take months for pharmaceutical companies to develop new vaccines for specific scale variants.
He also noted that the high number of Omicron mutations in the spike protein used by the virus to infect human cells, as well as the rapid spread of the mutation in South Africa, suggest that current vaccine production may need to be modified next year.
“I do not think there is an area where the vaccine is as effective as Delta,” Bansell told the Financial Times. “We have to wait for the data. the view that “this is not going to be good”.
The comments from Moderna’s CEO came at a time when other public health experts and politicians alike are trying to give a more optimistic tone about the ability of existing vaccines to provide protection against Omicron. Scott Gottlieb, director of Pfizer and former US Food and Drug Administration commissioner, told CNBC: “There is a reasonable degree of confidence in vaccine cycles that with at least three doses the patient will have fairly good protection against this variant.”
In this climate, the Dow Jones futures are losing 400 points or 1.1% at 34,672 points, the futures of the wider S&P 500 are slipping 0.8% to 4,610 points and the technology Nasdaq is falling 0.5% to 16,315 points .
In Monday’s session, Wall recovered some of its losses on Friday, with the Dow Jones gaining 236.60 points or 0.68% and closing at 35,135.94 points, its biggest daily gain in the last month. The S&P 500 was up 60.65 points, or 1.32%, at 4,655.27 points, the biggest gain since October 14, and the Nasdaq was up 291.18 points, or 1.88%, at 15,782. , 83 points marking its best rise since May 14.
Moderna jumped 11.8% on Monday, BioNTech rose 4.17% and Pfizer lost 2.96%.
.
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.
